The use of blood products to resuscitate injured and massively bleeding patients in the
prehospital and early in-hospital phase of the resuscitation is increasing. Using group O red …

Background: Whole blood transfusion is associated with benefits including improved
survival, coagulopathy, and decreased transfusion requirements. The majority of whole …

Background After the transfusion of RhD-positive red blood cell (RBC)-containing products
to an RhD-negative woman of childbearing potential (WCP) during trauma resuscitation …

Background A risk assessment model for predicting the risk of haemolytic disease of the
fetus and newborn (HDFN) in future pregnancies following the transfusion of Rh (D)‐positive …

Background and Objectives D‐negative red cells are transfused to D‐negative females of
childbearing potential (CBP) to prevent haemolytic disease of the foetus and newborn …

Background Evidence indicates the life‐saving benefits of early blood product transfusion in
severe trauma resuscitation. Many of these products will be RhD‐positive, so understanding …

The AABB recently posted a bulletin (19-02) regarding their recommendations for the use of
group O red blood cells (RBCs) during trauma. Though group O Rh (D)-negative RBC units …

Objectives To determine the rate of RhD-alloimmunization in injured RhD-negative patients
in the age range of childbearing potential who were transfused with at least one unit of RhD …

Background The use of blood products early in the resuscitation of bleeding trauma patients
is widely accepted, but made difficult by limited supplies of D− red blood cell (RBC) …

However, it appears, when reviewing the available evidence and weighing risks and
benefits, patients of childbearing potential who are DNEG or when the RhD type is unknown …